|
|||||||||||||||
|
INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT International Peer Reviewed & Refereed Journals, Open Access Journal ISSN Approved Journal No: 2456-4184 | Impact factor: 8.76 | ESTD Year: 2016 Scholarly open access journals, Peer-reviewed, and Refereed Journals, Impact factor 8.76 (Calculate by google scholar and Semantic Scholar | AI-Powered Research Tool) , Multidisciplinary, Monthly, Indexing in all major database & Metadata, Citation Generator, Digital Object Identifier(DOI) |
||||||||||||||
Issue: May 2024
Volume 9 | Issue 5
Review Result and Publication of Paper within : 2-3 days
Click Here For more DetailsFor Authors
Forms / Download
Published Issue Details
Editorial Board
Other IMP Links
Facts & Figure
Impact Factor : 8.76
Issue per Year : 12
Volume Published : 9
Issue Published : 96
Article Submitted :
Article Published :
Total Authors :
Total Reviewer :
Total Countries :
Indexing Partner
Join RMS/Earn 300
Licence
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
|
Published Paper Details
|
|
| Paper Title: | Recent Advance Study on Pharmacogenomics: A REVIEW |
| Authors Name: | Pooja B. Sankpal , Pritam Salokhe , Vaishnavi Gurav , Pavan Chavan , N.B. Chougule |
| Download E-Certificate: | Download |
| Author Reg. ID: |
IJNRD_215156
|
| Published Paper Id: | IJNRD2403181 |
| Published In: | Volume 9 Issue 3, March-2024 |
| DOI: | |
| Abstract: | Pharmacogenomics can enhance patient care by optimizing pharmacological selection and administration, minimizing the risk of side effects, and increasing patient and provider satisfaction. Over the last 10 years, genetic testing technology has advanced, and clinical evidence supporting pharmacogenomics' incorporation into clinical practice has gotten stronger. Pharmacogenomics is the application of genome-wide techniques to understand how genes influence drug response and to develop novel drugs. Pharmacogenomics is the study of how human gene information impacts medication response, with the goal of increasing efficacy while minimizing negative effects. The ultimate goal of pharmacogenomics is the belief that patients' DNA sequences may be utilized to enhance disease treatment therapy in order to optimize efficacy, target pharmaceuticals only to those who are likely to respond, and reduce adverse drug reactions (ADRs). This article provides an overview of pharmacogenomics research, which aims to identify the genes (and gene variants) responsible for a drug's interactions with the body. |
| Keywords: | Pharmacogenomics, Side effect, Medicines, Gene, Safety. |
| Cite Article: | "Recent Advance Study on Pharmacogenomics: A REVIEW", International Journal of Novel Research and Development (www.ijnrd.org), ISSN:2456-4184, Vol.9, Issue 3, page no.b714-b722, March-2024, Available :http://www.ijnrd.org/papers/IJNRD2403181.pdf |
| Downloads: | 00056 |
| ISSN: |
2456-4184 | IMPACT FACTOR: 8.76 Calculated By Google Scholar| ESTD YEAR: 2016 An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 8.76 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator |
| Publication Details: |
Published Paper ID:IJNRD2403181 Registration ID: 215156 Published In: Volume 9 Issue 3, March-2024 DOI (Digital Object Identifier): Page No: b714-b722 Country: kolhapur, maharashtra, India Research Area: Pharmacy Publisher : IJ Publication Published Paper URL : https://www.ijnrd.org/viewpaperforall?paper=IJNRD2403181 Published Paper PDF: https://www.ijnrd.org/papers/IJNRD2403181 |
| Share Article: |
|
|
Click Here to Download This Article |
|
| Article Preview | |
|
|
|
Major Indexing from www.ijnrd.org
| Semantic Scholar | Microsaoft Academic | ORCID | Zenodo |
| Google Scholar | ResearcherID Thomson Reuters | Mendeley : reference manager | Academia.edu |
| arXiv.org : cornell university library | Research Gate | CiteSeerX | PUBLON |
| DRJI | SSRN | Scribd | DocStoc |
ISSN Details
 |
 |
|
ISSN: 2456-4184
Impact Factor: 8.76 and ISSN APPROVED
Journal Starting Year (ESTD) : 2016
DOI (A digital object identifier)
Conference
Open Access License Policy
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
Important Details
Social Media
Licence
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
Join RMS/Earn 300
| Copyright © 2024 - All Rights Reserved - IJNRD |
Facebook Twitter Instagram LinkedIn